Results 81 to 90 of about 103,527,733 (191)

Protective Activity of Esculetin Against 3-Nitropropionic Acid Induced Neurotoxicity Via Scavenging Reactive Oxygen Species in Male Wistar Rats

open access: yes, 2017
Huntington’s disease (HD) is a devastating neurodegenerative disorder with no cure till date. Many genetic or chemically induced models have been developed in rodents to study the disease. 3-Nitropropionic (3-NP) acid is a well-known neurotoxin to induce
Arpita Karandikar, Sumathi Thangarajan
core   +1 more source

A short review on toxin-induced animal models of Huntington’s disease

open access: yesChronic Diseases Journal
BACKGROUND: Huntington's disease (HD) is a hereditary neurodegenerative motor and cognitive disorder. Different animal models of HD have been provided to study the different aspects of the disease, such as pathophysiology and treatment, and also the cure.
Ahmad Fotoohi
doaj   +1 more source

Striatal and Cortical Neurochemical Changes Induced by Chronic Metabolic Compromise in the 3-Nitropropionic Model of Huntington's Disease

open access: yesNeurobiology of Disease, 2002
In the present study, we aimed to determine the time-course of neurochemical changes occurring following metabolic impairments produced by 3-nitropropionic (3NP) acid in a rat model of Huntington's disease.
David Blum   +4 more
doaj   +1 more source

Energy and Glutamate Dependency of 3-Nitropropionic Acid Neurotoxicity in Culture

open access: yesExperimental Neurology, 1996
3-Nitropropionic acid (3-NP) irreversibly inhibits the activity of the mitochondrial enzyme succinate dehydrogenase, leading to selective striatal lesions when administered in vivo. We studied the effects of 3-NP on dissociated cultures of neurons and glia with the following findings: (a) 3-NP killed cultured striatal neurons with a median lethal dose ...
S L, Fink, D Y, Ho, R M, Sapolsky
openaire   +2 more sources

Quercetin Improves Behavioral Deficiencies, Restores Astrocytes and Microglia, and Reduces Serotonin Metabolism in 3-Nitropropionic Acid-Induced Rat Model of Huntington’s Disease

open access: yes, 2014
Huntington’s disease (HD) is an autosomal dominant disorder, for which clinically available drugs offer only symptomatic relief. These prescription drugs are not free of side effects, and the patients usually suffer from anxiety and depression.
Mohanakumar, Kochupurackal P.   +11 more
core   +1 more source

Combining Lycopene, Quercetin, and Poloxamer 188 Therapy Reduces Learning and Memory Deficits in the 3-nitropropionic Acid-induced Rat Model of Huntington's Disease

open access: yes
Introduction: The current study was carried out to assess the pharmacological action of combine effect of Poloxamer 188, Lycopene, and Quercetin on memory and energy deficit in Huntington’s disease-like signs ...
Suchita P. Dhamane   +4 more
core   +1 more source

Additional file 3: Figure S3. of Drug discovery using clinical outcome-based Connectivity Mapping: application to ovarian cancer

open access: yes, 2016
The dose response data for 3-nitropropionic acid across the 10 EOC cell lines.
Ellen Goode (3445394)   +7 more
core   +1 more source

Schisandra chinensis Stem Ameliorates 3-Nitropropionic Acid-Induced Striatal Toxicity via Activation of the Nrf2 Pathway and Inhibition of the MAPKs and NF-κB Pathways

open access: yesFrontiers in Pharmacology, 2017
The beneficial value of the stems of Schisandra chinensis (SSC) in neurological diseases is unclear. We examined whether SSC aqueous extract (SSCE) alleviates striatal toxicity in a 3-nitropropionic acid (3-NPA)-induced mouse model of Huntington's ...
Eun-Jeong Kim   +17 more
doaj   +1 more source

Effect of 3-NPA-induced ovarian oxidative stress on reproductive ability.

open access: yes, 2014
Data are presented as mean ± SEM ...
Shao-Chen Sun (257797)   +8 more
core   +1 more source

A novel arylpiperazine derivative (LQFM181) protects against neurotoxicity induced by 3- nitropropionic acid in in vitro and in vivo models [PDF]

open access: yes
In the pursuit of novel antioxidant therapies for the prevention and treatment of neurodegenerative diseases, three new arylpiperazine derivatives (LQFM181, LQFM276, and LQFM277) were synthesized through a molecular hybridization approach involving ...
Cínthia Rio Branco da Silva   +20 more
core   +1 more source

Home - About - Disclaimer - Privacy